As used in the Wholesale Prescription Drug Importation Act: A. "Canadian supplier" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs; B. "committee" means the prescription drug importation advisory committee; C. "department" or "authority" means the health care authority department; D. "eligible prescription drug" means a drug eligible for importation that: (1) meets the United States food and drug administration's standards related to safety, effectiveness, misbranding and adulteration; (2) does not violate federal patent laws; (3) is expected to generate cost savings; and (4) is not a controlled substance; E. "program" means the wholesale prescription drug importation program; and F. "state drug wholesaler" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier. History: Laws 2020, ch. 45, § 2; 2024, ch. 39, § 58.